Daniel J. Weston

1.5k total citations
39 papers, 1.2k citations indexed

About

Daniel J. Weston is a scholar working on Spectroscopy, Molecular Biology and Analytical Chemistry. According to data from OpenAlex, Daniel J. Weston has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Spectroscopy, 15 papers in Molecular Biology and 6 papers in Analytical Chemistry. Recurrent topics in Daniel J. Weston's work include Mass Spectrometry Techniques and Applications (20 papers), Analytical Chemistry and Chromatography (17 papers) and Metabolomics and Mass Spectrometry Studies (7 papers). Daniel J. Weston is often cited by papers focused on Mass Spectrometry Techniques and Applications (20 papers), Analytical Chemistry and Chromatography (17 papers) and Metabolomics and Mass Spectrometry Studies (7 papers). Daniel J. Weston collaborates with scholars based in United Kingdom, United States and Singapore. Daniel J. Weston's co-authors include Colin S. Creaser, Robert A. Wise, Ian D. Wilson, Robert Bateman, B J Crump, James C. Reynolds, J Dent, Ian D. Wilson, Anthony W. T. Bristow and Philip Bonner and has published in prestigious journals such as Analytical Chemistry, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Daniel J. Weston

37 papers receiving 1.1k citations

Peers

Daniel J. Weston

SPECT

PHARM

Emmanuel Varesio Switzerland

Robert D. Voyksner United States

Tsung‐Chi Chen United States

R. E. Kaiser United States

Jim X Shen United States

Constance M. Murphy United States

Frank S. Pullen United Kingdom

Nele Matthijs Belgium

Ben L. M. van Baar Netherlands

Mark A. Strege United States

Emmanuel Varesio Switzerland

Daniel J. Weston

1.7k ×2.3

SPECT

1.2k ×3.6

287 ×1.2

584 ×2.6

152 ×1.2

PHARM

Citations per year, relative to Daniel J. Weston Daniel J. Weston (= 1×) peers Emmanuel Varesio

Countries citing papers authored by Daniel J. Weston

Since Specialization

Citations

This map shows the geographic impact of Daniel J. Weston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Weston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Weston more than expected).

Fields of papers citing papers by Daniel J. Weston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. Weston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Weston. The network helps show where Daniel J. Weston may publish in the future.

Co-authorship network of co-authors of Daniel J. Weston

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel J. Weston. A scholar is included among the top collaborators of Daniel J. Weston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel J. Weston. Daniel J. Weston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weston, Daniel J., et al.. (2024). Alpibectir: Early Qualitative and Quantitative Metabolic Profiling from a First-Time-in-Human Study by Combining 19F-NMR (Nuclear Magnetic Resonance), 1H-NMR, and High-Resolution Mass Spectrometric Analyses. Drug Metabolism and Disposition. 52(8). 858–874. 3 indexed citations

Weston, Daniel J., et al.. (2020). Increase in reported domestic abuse in Integrated Sexual Health (ISH) services in London and Surrey during COVID-19 ‘lockdown’: successful application of national guidance on routine enquiry during rapid transition to remote telephone consultation (telemedicine). Sexually Transmitted Infections. 97(3). 245–246. 7 indexed citations

Weston, Daniel J., et al.. (2020). Coronavirus (COVID-19) and young people’s sexual health. Sexually Transmitted Infections. 96(7). 473–474. 24 indexed citations

Hogg, Karen, Jerry R. Thomas, David A. Ashford, et al.. (2015). Quantification of proteins by flow cytometry: Quantification of human hepatic transporter P-gp and OATP1B1 using flow cytometry and mass spectrometry. Methods. 82. 38–46. 15 indexed citations

Fontanella, Cynthia A., et al.. (2014). Quality of Care for Medicaid-Enrolled Youth with Bipolar Disorders. Administration and Policy in Mental Health and Mental Health Services Research. 42(2). 126–138. 9 indexed citations

Smith, Robert W., James C. Reynolds, Anthony W. T. Bristow, et al.. (2013). Enhanced performance in the determination of ibuprofen 1-β-O-acyl glucuronide in urine by combining high field asymmetric waveform ion mobility spectrometry with liquid chromatography-time-of-flight mass spectrometry. Journal of Chromatography A. 1278. 76–81. 18 indexed citations

Reynolds, James C., et al.. (2012). Direct extraction of urinary analytes from undeveloped reversed-phase thin layer chromatography plates using a solvent gradient combined with on-line electrospray ionisation ion mobility-mass spectrometry. The Analyst. 137(15). 3510–3510. 2 indexed citations

Berkel, Gary J. Van, Kathryn Pickup, Roderic O. Cole, et al.. (2011). Utility of spatially-resolved atmospheric pressure surface sampling and ionization techniques as alternatives to mass spectrometric imaging (MSI) in drug metabolism. Xenobiotica. 41(8). 720–734. 32 indexed citations

Reynolds, James C., et al.. (2011). Determination of free desmosine and isodesmosine as urinary biomarkers of lung disorder using ultra performance liquid chromatography–ion mobility-mass spectrometry. Journal of Chromatography B. 879(32). 3797–3801. 16 indexed citations

10.

Beattie, Iain G., et al.. (2011). Evaluation of laser diode thermal desorption (LDTD) coupled with tandem mass spectrometry (MS/MS) for support of in vitro drug discovery assays: Increasing scope, robustness and throughput of the LDTD technique for use with chemically diverse compound libraries. Journal of Pharmaceutical and Biomedical Analysis. 59. 18–28. 14 indexed citations

11.

Weston, Daniel J., et al.. (2008). Immobilised Metal Affinity Chromatography for the Analysis of Proteins and Peptides. Current Analytical Chemistry. 4(2). 127–135. 12 indexed citations

12.

Weston, Daniel J., et al.. (2008). An approach to enhancing coverage of the urinary metabonome using liquid chromatography–ion mobility–mass spectrometry. Journal of Chromatography B. 871(2). 357–361. 38 indexed citations

13.

Matharoo‐Ball, Balwir, Lucy Ratcliffe, Lee Lancashire, et al.. (2007). Diagnostic biomarkers differentiating metastatic melanoma patients from healthy controls identified by an integrated MALDI‐TOF mass spectrometry/bioinformatic approach. PROTEOMICS - CLINICAL APPLICATIONS. 1(6). 605–620. 28 indexed citations

14.

Weston, Daniel J., et al.. (2007). On-line capillary column immobilised metal affinity chromatography/electrospray ionisation mass spectrometry for the selective analysis of histidine-containing peptides. Journal of Chromatography B. 857(2). 240–245. 6 indexed citations

15.

Weston, Daniel J., et al.. (2007). Analysis of tryptic peptides using desorption electrospray ionisation combined with ion mobility spectrometry/mass spectrometry. Rapid Communications in Mass Spectrometry. 21(7). 1131–1138. 47 indexed citations

16.

Xu, Ruo, Shengjian Li, Mark D. McBriar, et al.. (2006). Bicyclic[4.1.0]heptanes as phenyl replacements for melanin concentrating hormone receptor antagonists. Bioorganic & Medicinal Chemistry. 14(10). 3285–3299. 22 indexed citations

17.

McBriar, Mark D., Henry Guzik, Sherry Shapiro, et al.. (2006). Bicyclo[3.1.0]hexyl urea melanin concentrating hormone (MCH) receptor-1 antagonists: Impacting hERG liability via aryl modifications. Bioorganic & Medicinal Chemistry Letters. 16(16). 4262–4265. 11 indexed citations

18.

Wu, Wen‐Lian, Duane A. Burnett, Mary Ann Caplen, et al.. (2006). Design and synthesis of orally efficacious benzimidazoles as melanin-concentrating hormone receptor 1 antagonists. Bioorganic & Medicinal Chemistry Letters. 16(14). 3674–3678. 12 indexed citations

19.

Weston, Daniel J., et al.. (2006). Analysis of pharmaceutical formulations using atmospheric pressure ion mobility spectrometry combined with liquid chromatography and nano-electrospray ionisation. The Analyst. 132(1). 34–40. 30 indexed citations

20.

Nunn, Martha E., et al.. (2002). DEVELOPMENT AND PERCEIVED BENEFITS OF PERFORMANCE SPECIFICATIONS IN THE UK. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact